A Case of Septic Arthritis Caused by Persistent MRSA Bacteremia with Successful Treatment Through Linezolid.

Author: Sun Bean KIM ¹ ; Dong Hyun OH ; Yong Chan KIM ; Min Hyung KIM ; Je Eun SONG ; Jin Young AHN ; Su Jin JEONG ; Nam Su GOO ; Hye Won KIM ; Sang Hoon HAN ; Jun Yong CHOI ; Young Goo SONG ; June Myung KIM
Author Information

1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. shhan74@yuhs.ac
Publication Type:In Vitro ; Case Report
Keywords: Methicillin-Resistant Staphylococcus aureus; Bacteremia; Infectious arthritis; Vancomycin; Linezolid
MeSH: Acetamides; Arthritis, Infectious; Bacteremia; Humans; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Treatment Failure; Vancomycin
From:Infection and Chemotherapy 2012;44(5):403-406
CountryRepublic of Korea
Language:Korean
Abstract: Vancomycin is the primary antibiotic administered for treatment of methicillin-resistant S. aureus (MRSA) infection; however, treatment failure of vancomycin is currently not uncommon in patients with in vitro vancomycin susceptibile S. aureus (MIC < or = 2 microg/mL) infection. In this report, we describe a case of septic arthritis caused by persistent MRSA bacteremia and treated successfully with linezolid after failure of initial vancomycin therapy.